Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Pavblu™ (aflibercept-ayyh) – New biosimilar launch

October 30, 2024 - Amgen launched Pavblu (aflibercept-ayyh), biosimilar to Regeneron’s Eylea® (aflibercept).

Download PDF

Rx navigation